FOXP1 has been reported to be associated several human malignancies, including endometrial cancer, lung cancer, head and neck cancer, prostate cancer, renal cell carcinoma, ovarian carcinoma, osteosarcoma, hepatocellular carcinoma and B cell lymphoma [33, 47, 55–60]. Here, FOXP1 is linked to ovarian carcinoma.